Literature DB >> 21151209

Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic.

Claudia Seikrit1, Anja Mühlfeld, Hermann-Josef Groene, Jürgen Floege.   

Abstract

BACKGROUND: A 47-year-old man with a 6-year history of chronic dialysis for end-stage renal disease of unknown etiology presented for renal transplantation. While on dialysis, he had developed secondary hyperparathyroidism, which persisted after transplantation despite treatment with cinacalcet. INVESTIGATIONS: Physical examination, serum and urine analysis, ultrasound of the renal transplant, renal biopsy, bone scintigraphy. DIAGNOSIS: Severe persistent hyperparathyroidism associated with mild hypercalcemia following renal transplantation. Initiation of a calcimimetic followed by fulminant graft failure. Extensive tubular calcinosis. MANAGEMENT: Renal transplantation (with immunosuppressant medications: basiliximab, tacrolimus, mycophenolate mofetil, prednisolone), cinacalcet (halted on day 26 after transplantation), angiotensinconverting-enzyme inhibitor, angiotensin-receptor blocker, hydrochlorothiazide, emergency dialysis, subtotal parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21151209     DOI: 10.1038/nrneph.2010.169

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  23 in total

Review 1.  Parathyroidectomy after successful kidney transplantation: a single centre study.

Authors:  Pieter Evenepoel; Kathleen Claes; Dirk R Kuypers; Frans Debruyne; Yves Vanrenterghem
Journal:  Nephrol Dial Transplant       Date:  2007-03-19       Impact factor: 5.992

2.  Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.

Authors:  Ilan Szwarc; Angel Argilés; Valérie Garrigue; Sylvie Delmas; Guillaume Chong; Sébastien Deleuze; Georges Mourad
Journal:  Transplantation       Date:  2006-09-15       Impact factor: 4.939

3.  Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.

Authors:  Andreas L Serra; Reto Savoca; Andreas R Huber; Urs Hepp; Aba Delsignore; Martin Hersberger; Rudolf P Wüthrich
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

4.  The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.

Authors:  Anja E Kruse; Ute Eisenberger; Felix J Frey; Markus G Mohaupt
Journal:  Nephrol Dial Transplant       Date:  2005-06-07       Impact factor: 5.992

5.  Calcium levels as a risk factor for delayed graft function.

Authors:  Henk Boom; Marko J K Mallat; Johan W de Fijter; Leendert C Paul; Jan A Bruijn; Leendert A van Es
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

6.  Calcium metabolism in the early posttransplantation period.

Authors:  Pieter Evenepoel; Barbara Van Den Bergh; Maarten Naesens; Hylke De Jonge; Bert Bammens; Kathleen Claes; Dirk Kuypers; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

7.  Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.

Authors:  Pieter Evenepoel; Kathleen Claes; Dirk Kuypers; Bart Maes; Bert Bammens; Yves Vanrenterghem
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

Review 8.  Bartter syndrome.

Authors:  Steven C Hebert
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-09       Impact factor: 2.894

9.  Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure.

Authors:  Ogo I Egbuna; Jeremy G Taylor; David A Bushinsky; Martin S Zand
Journal:  Clin Transplant       Date:  2007 Jul-Aug       Impact factor: 2.863

10.  Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation.

Authors:  A L Serra; S C Braun; A Starke; R Savoca; M Hersberger; S Russmann; N Corti; R P Wüthrich
Journal:  Am J Transplant       Date:  2008-03-02       Impact factor: 8.086

View more
  4 in total

1.  Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy.

Authors:  Kentaro Nakai; Hideki Fujii; Mikiko Yoshikawa; Keiji Kono; Yuriko Yonekura; Shunsuke Goto; Takeshi Ishimura; Masashi Takeda; Masato Fujisawa; Shinichi Nishi
Journal:  Clin Exp Nephrol       Date:  2015-03-18       Impact factor: 2.801

2.  Vitamin D and cinacalcet administration pre-transplantation predict hypercalcaemic hyperparathyroidism post-transplantation: a case-control study of 355 deceased-donor renal transplant recipients over 3 years.

Authors:  Frank-Peter Tillmann; Carolin Wächtler; Anita Hansen; Lars Christian Rump; Ivo Quack
Journal:  Transplant Res       Date:  2014-12-31

3.  Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation.

Authors:  Ursula Thiem; Alois Gessl; Kyra Borchhardt
Journal:  Biomed Res Int       Date:  2015-03-10       Impact factor: 3.411

Review 4.  Mineral and Bone Disorders After Kidney Transplantation.

Authors:  Chandan Vangala; Jenny Pan; Ronald T Cotton; Venkat Ramanathan
Journal:  Front Med (Lausanne)       Date:  2018-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.